Residual Thrombosis: Still Relevant in the Direct Oral Anticoagulant (DOAC) Era?
Thrombosis and Haemostasis · 01.08.2023 · 123 (08) · 747-749
DOI: 10.1055/a-2102-0376 ↗Kurz gefasst
Fachartikel in der Zeitschrift Thrombosis and Haemostasis, erschienen am 01.08.2023. Verfasst von Cecilia Becattini und 1 weiteren Autor:innen. Beteiligte Einrichtung: Internal and Cardiovascular Medicine, Stroke Unit, University of Perugia, Perugia, Italy. Hauptthemen laut MEDLINE: Thrombosis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 17 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Internal and Cardiovascular Medicine, Stroke Unit, University of Perugia, Perugia, Italy.
Zitieren
APA
Becattini, C., & Agnelli, G. (2023). Residual Thrombosis: Still Relevant in the Direct Oral Anticoagulant (DOAC) Era?. Thrombosis and Haemostasis, 123(08), 747-749. https://doi.org/10.1055/a-2102-0376
Vancouver
Becattini C, Agnelli G. Residual Thrombosis: Still Relevant in the Direct Oral Anticoagulant (DOAC) Era?. Thrombosis and Haemostasis. 2023;123(08):747-749. doi:10.1055/a-2102-0376
BibTeX
@article{Becattini2023,
author = {Becattini, Cecilia and Agnelli, Giancarlo},
title = {Residual Thrombosis: Still Relevant in the Direct Oral Anticoagulant (DOAC) Era?},
journal = {Thrombosis and Haemostasis},
year = {2023},
volume = {123},
number = {08},
pages = {747--749},
doi = {10.1055/a-2102-0376}
}
EUVIMED